Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: August 31, 2020

  1. Home>
  2. 2020>
  3. August>
  4. 31
No, ‘Plandemic’ Isn’t Telling You the Truth About COVID-19
source: pixabay.com

No, ‘Plandemic’ Isn’t Telling You the Truth About COVID-19

  • Post author:Jessica Lynn
  • Post published:August 31, 2020
  • Post category:COVID-19

There are over 24 million diagnosed cases of COVID-19 worldwide, with over 800,000 associated deaths. The viral pandemic certainly has people feeling upset, confused, and vulnerable. Unfortunately, some resources are…

Continue Reading No, ‘Plandemic’ Isn’t Telling You the Truth About COVID-19
FDA Accepts Casimersen NDA for Patients with Exon 45 Amenable DMD
PublicDomainPictures / Pixabay

FDA Accepts Casimersen NDA for Patients with Exon 45 Amenable DMD

  • Post author:Jessica Lynn
  • Post published:August 31, 2020
  • Post category:Duchenne Muscular Dystrophy

Earlier this week, Sarepta Therapeutics announced that the FDA approved a New Drug Application (NDA) for Casimersen (SRP-4045). The treatment, for patients with exon 45 amenable Duchenne muscular dystrophy (DMD),…

Continue Reading FDA Accepts Casimersen NDA for Patients with Exon 45 Amenable DMD
Phase 1/2a Trial Will Investigate Engensis for CMT1A
source: pixabay.com

Phase 1/2a Trial Will Investigate Engensis for CMT1A

  • Post author:Jessica Lynn
  • Post published:August 31, 2020
  • Post category:Charcot-Marie-Tooth disease

According to Charcot-Marie-Tooth News, biotechnology company Helixmith recently began a Phase 1/2a clinical trial to test the efficacy of Engensis (VM202) for patients with Charcot-Marie-Tooth disease type 1A (CMT1A). The…

Continue Reading Phase 1/2a Trial Will Investigate Engensis for CMT1A
Could HP163 for Zika Virus Prevent COVID-19 Replication?
Source: www.pixabay.com

Could HP163 for Zika Virus Prevent COVID-19 Replication?

  • Post author:Jessica Lynn
  • Post published:August 31, 2020
  • Post category:COVID-19/Zika Virus

What do microcephaly, Zika virus, Dengue fever, and COVID-19 have in common? According to a recent press release,  HP163 could be a treatment for all four. Developed by biopharmaceutical company…

Continue Reading Could HP163 for Zika Virus Prevent COVID-19 Replication?
Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment
source: pixabay.com

Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment

  • Post author:James Moore
  • Post published:August 31, 2020
  • Post category:Hepatocellular Carcinoma/Pancreatic Cancer

According to a story from BioSpace, the biotechnology company Tiziana Life Sciences plc has announced that it was recently granted a patent from the United States Patent and Trademark Office…

Continue Reading Company Obtains Patent for Hepatocellular Carcinoma Combination Treatment
Dosing Begins in Trial of NASH Treatment
source: pixabay.com

Dosing Begins in Trial of NASH Treatment

  • Post author:Kendall Mason
  • Post published:August 31, 2020
  • Post category:Nonalcoholic steatohepatitis/Rare Disease

CohBar has initiated dosing in their Phase 1b trial of CB4211, which is a treatment for nonalcoholic steatohepatitis (NASH). The biotechnology company focuses on mitochondria based therapies with the goal…

Continue Reading Dosing Begins in Trial of NASH Treatment
An Experimental Drug for Alzheimer’s is Being Tested to Treat Autism

An Experimental Drug for Alzheimer’s is Being Tested to Treat Autism

  • Post author:Rose Duesterwald
  • Post published:August 31, 2020
  • Post category:ADNP Syndrome/Alzheimer's disease without Neurofibrillary tangles/Rare Disease

Professor Illana Gozes and her team at Tel Aviv University recently developed NAP (CP201). It is an experimental drug that has been proven to be effective in the treatment of…

Continue Reading An Experimental Drug for Alzheimer’s is Being Tested to Treat Autism
New Evidence on Dietary Restrictions for Those With Chronic Kidney Disease

New Evidence on Dietary Restrictions for Those With Chronic Kidney Disease

  • Post author:Kendall Mason
  • Post published:August 31, 2020
  • Post category:Chronic Kidney Disease

The importance of potassium restrictions in the diets of chronic kidney disease (CKD) patients has been stressed for years. It lowers levels of serum potassium, therefore lowering the mortality risk.…

Continue Reading New Evidence on Dietary Restrictions for Those With Chronic Kidney Disease

Featured


Picture of Family


Metastatic Breast Cancer: Navigating Grief


Picture of Ralph Family walking


Rethinking What It Means to Live With Acromegaly


Illustration of mentor program members


The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info